Similar articles

• Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.

  Strober W, Asano N, Fuss I, Kitani A, Watanabe T. Strober W, et al. Immunol Rev. 2014 Jul;260(1):249-60. doi: 10.1111/imr.12193. Immunol Rev. 2014. PMID: 24942694 Review.
• Crohn's disease.

  Shanahan F. Shanahan F. Lancet. 2002 Jan 5;359(9300):62-9. doi: 10.1016/S0140-6736(02)07284-7. Lancet. 2002. PMID: 11809204 Review.
• Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn's disease.

  Hruz P, Eckmann L. Hruz P, et al. Swiss Med Wkly. 2010 Dec 27;140:w13135. doi: 10.4414/smw.2010.13135. eCollection 2010. Swiss Med Wkly. 2010. PMID: 21213148 Review.
• Dysbiotic gut microbiome: A key element of Crohn's disease.

  Øyri SF, Műzes G, Sipos F. Øyri SF, et al. Comp Immunol Microbiol Infect Dis. 2015 Dec;43:36-49. doi: 10.1016/j.cimid.2015.10.005. Epub 2015 Oct 25. Comp Immunol Microbiol Infect Dis. 2015. PMID: 26616659 Review.
• Bacterial invasion: linking autophagy and innate immunity.

  Galluzzi L, Kepp O, Zitvogel L, Kroemer G. Galluzzi L, et al. Curr Biol. 2010 Feb 9;20(3):R106-8. doi: 10.1016/j.cub.2009.12.016. Curr Biol. 2010. PMID: 20144769